RNA Dividend History & Analysis | N/A Yield

RNA has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

As of November 2025, Avidity Biosciences (RNA) does not pay a dividend.

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap (USD) Dividend Yield TTM Yield on Cost (purchase 5y ago)
JBIO 280 M 24.5% 0.31%
ABBV 387,340 M 2.91% 8.05%
GILD 152,766 M 2.56% 6.31%
AMGN 172,422 M 2.77% 4.60%
HLN 41,279 M 1.79% 2.46%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap (USD) Growth Rate (CAGR) Payout Consistency
GRFS 7,207 M 127% 60.7%
HLN 41,279 M 51.0% 100%
AMGN 172,422 M 8.90% 100%
ABBV 387,340 M 7.06% 100%
GILD 152,766 M 3.16% 100%

Similar Stocks with Attractive Dividends - Compare RNA Dividends with its Peer-Group

ABBV
AbbVie
2.91% Yield
AMGN
Amgen
2.77% Yield
GILD
Gilead Sciences
2.56% Yield
HLN
Haleon
1.79% Yield

RNA Dividend History: as of November 2025

No dividends paid yet.

RNA Dividend FAQ

Avidity Biosciences (NASDAQ:RNA) is a San-Diego-based biopharma that develops antibody-oligonucleotide conjugates (AOCs), marrying monoclonal-antibody targeting with RNA-based gene-silencing to reach disease mechanisms that conventional biologics cannot.

What is the Dividend Yield of RNA?

As of November 2025, RNA`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 70.70.

Does RNA pay a dividend?

As of November 2025 RNA does not pay a dividend.

How often does RNA pay dividends?

Over the last 12 months, RNA has issued dividend payments.

Will RNA pay dividends in 2025?

The next Ex-Dividend date for Avidity Biosciences (RNA) is currently unknown.

What is the next Ex-Dividend Date for RNA?

The next Ex-Dividend date for Avidity Biosciences (RNA) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of RNA?

RNA's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of RNA?

RNA's 5-Year Yield on Cost is -%. If you bought RNA's shares at 29.20 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of RNA?

RNA Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does RNA have a good Dividend Yield?

RNA`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of RNA?

The Dividend Payout Ratio of RNA is unknown.

What is the Dividend Rating of RNA?

RNA`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

RNA Outstanding Shares Analysis

What is the Trend in RNA`s Outstanding Shares (CAGR)?

Avidity Biosciences`s outstanding shares have increased by approximately 30.55% annually over the past 3 years (Correlation: 100.0%), negatively influencing the share price.

Has Avidity Biosciences ever had a Stock Split?

No Stock Splits found.
Year Number of Shares Annual Growth Rate
2014 52,857,900
2018 2,000,000
2019 20,682,000 +934.1%
2020 37,455,000 +81.1%
2021 23,607,500 -36.97%
2022 57,296,000 +142.7%
2023 76,052,000 +32.74%
2024 128,497,000 +68.96%
2025 129,622,000 +0.88%

Key Metric Definitions

  • Dividend Yield: Annual dividend per share divided by current share price.
  • Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
  • Payout Ratio: Percentage of earnings paid as dividends (TTM).
  • Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
  • Payout Frequency: Number of dividends paid in the last 12m (TTM).
  • Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
  • Total Return: Price appreciation plus dividends over specified period.
  • Market Cap: Figures are in millions of the corresponding currency.

Last update: 2025-11-07 02:36